To help patients who have undergone radiotherapy to minimize its after effects
Discover ARSER
The Board of Directors
The Board of Directors is the operational management body of the Association. Its members are elected by the members during a General Assembly. Their term of office is three years. The Board of Directors elects its officers: President, Vice-President, General Secretary and Treasurer.
The current Board of Directors is comprised of: President: Prof. Sylvie DELANIAN – Vice-Chairman: Prof. Pierre-François PRADAT – General Secretary: Roselyne NICOLAS – Treasurer: Benoit BRUET – External Relations Manager: Jean-Pierre BRIOT – Delegations: Brittany: Jean VALLÉE – Occitania: Hans CARL.
The Scientific Council supports the Association at national level. The Board of Directors chooses its members for a renewable two years term. The role of the Scientific Council is defined in the rules and regulations.
Scientific Council current members are:
Pr Pierre-François PRADAT – SC President – MD, PhD, Hospital Physician, Researcher (Département des Maladies du Système Nerveux – Hôpital de la Pitié-Salpêtrière – APHP – Paris), Neurosciences Professor (Ulster University – United Kingdom)
Pr Sylvie DELANIAN – SC Vice-President – MD, PhD, Hospital Physician in Oncology-Radiotherapy, Radiopathology, Fibrosis (Saint-Louis Hospital – APHP – Paris), Professor at Collège de Médecine (PH)
Dr Sameh AWAD – MD, Former HP at Georges Pompidou Hospital, PA at Paul Brousse Hospital, Vascular and Interventional Radiologist, Member of Société Française de Radiologie, of Société Francophone de l’Abord Vasculaire, of Société Française d’Imagerie Cardiaque et Vasculaire, and of Société Européenne de Radiologie Cardiovasculaire et Interventionnelle
Pr Céline BOURGIER – MD, PhD, University Professor (MCU), Hospital Practitioner, Director of École du Cancer, Oncology-Radiotherapy & Radiopathology (Institut du Cancer de Montpellier – ICM)
Dr Cécile CHATEL – Odontology Doctor, Hospital Praticioner, Odontologist at Service de Chirurgie Plastique et Maxillofaciale (Grenoble CHU)
Dr Alexandra FOURCADE – MD, Public Heath Specialist at Heath Ministry, Deputy Mayor of Neuilly-sur-Seine
Pr Mehdi KAROUI – MD, PhD, University Professor, Hospital Praticioner, Visceral and Digestive Surgery, Head of Service at Hospital Georges Pompidou (APHP – Paris), Board of Collège de Chirurgie and of Conseil National des Universités de Chirurgie Viscérale et digestive
Jean-Louis LEFAIX – PhD, Former Researcher in Radiobiology-Radiopathology at Laboratoire de Recherche de Radiobiologie du Commissariat à l’Énergie Atomique (CEA – Caen)
Dr Gwendoline SEBILLE – MD, Liberal Dermatologist at Centre Laser (Paris – CLIPP), DIU in Dermatology, Former Junior Doctor at Strasbourg CHU, Former Resident at Gustave-Roussy Hospital, Member of Société Française de Dermatologie and of Groupe Laser
Dr Stéphane VIGNES – MD, Head of Service Lymphology Unit at Hospital Cognacq-Jay (Paris), Centre de Référence des Maladies Vasculaires Rares
Pr Marie-Catherine VOZENIN – PhD, University Professor, Researcher in Radiobiology-Radiopathology, Director of Radio-Oncology Research Laboratory (Lausanne CHUV – Switzerland)
Why ARSER?
Dr. Sylvie DELANIAN – Oncologist-Radiotherapist, Saint-Louis Hospital:
It’s a great hope because she is characterized by her relevance to the subject, on the one hand, and her lack of belligerence, i.e. the objective is not to protest or to say “Why me?”
…Well, there is the view that it is inevitable, but at the same time, what can we do?
That is, this is an ongoing issue. We already have in this association digested the pill of: “too bad, it would have been preferable not to happen; but now that it has happened, what to do?”. Governments handle very well what is upstream, i.e. prevention, making radiation therapy more focused, smarter, more intelligent. But anyway, whatever we do, there will always be a small contingent and this small contingent is composed of people who exist. Behind the scans, there is someone, that someone needs to be helped, and I may be one of the people who can help them.
Dr. Pierre-François PRADAT – Neurologist, La Pitié-Salpêtrière Hospital:
I especially had the good fortune to meet Mr Hervé LIONEL-MARIE and to realize that what he could bring to this topic interested me and was absolutely critical and that he could bring elements that I was unable to provide. Then we talked about the research funding; it is true that there is institutional financing, but it is insufficient. Therefore, there is a need for society to come and support. So the role of an association in this context is absolutely essential. Moreover, there is a need to interact with public authorities. And we know that the present evolution is probably a positive evolution and that the contacts for government authorities are no longer doctors but are patient associations. So the era of ministers first consulting powerful doctors is a thing of the past. Therefore, we need people who are affected by the disease but who also have a broader scope than our technical vision, which is necessarily a derivative of medical problems.
Download video transcript (319KB)
Nous utilisons des cookies pour vous garantir la meilleure expérience sur notre site notamment au niveau de la sécurité. Ils ne sont pas utilisés à des fins commerciales. Si vous continuez à utiliser notre site, nous considérerons que vous acceptez l'utilisation des cookies. S'ils ne sont pas activés sur votre navigateur, vous pourriez ne pas avoir accès à certaines fonctionnalités (l'annuaire par exemple). Vous trouverez sur ce lien la méthode pour les activer pour notre site. Merci de votre compréhension.Ok
